Triple-negative breast cancer (TNBC), defined as not expressing the estrogen receptor (ER), the progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), accounts for nearly one fifth of all BCs (7). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.